Clinical Trial Update: Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update for platelet rich plasma eye drops in ocular surface disease and dry eye syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndromes
• Ocular Surface Disease

Drugs mentioned

• Platelet-rich plasma eye drops (platelet-rich plasma)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Ocular Surface Disease, Dry Eye Syndromes | Phase 4 | Status: UNKNOWN